Goldman Sachs Group set a €65.00 ($75.58) target price on Gerresheimer (ETR:GXI) in a report published on Monday. The brokerage currently has a neutral rating on the stock.

Other equities analysts have also issued reports about the company. JPMorgan Chase & Co. set a €66.00 ($76.74) price target on Gerresheimer and gave the stock a neutral rating in a research report on Monday, October 15th. Berenberg Bank set a €81.00 ($94.19) price target on Gerresheimer and gave the stock a buy rating in a research report on Thursday, January 31st. Hauck & Aufhaeuser set a €55.00 ($63.95) price target on Gerresheimer and gave the stock a neutral rating in a research report on Monday, October 15th. Deutsche Bank set a €86.00 ($100.00) price target on Gerresheimer and gave the stock a buy rating in a research report on Tuesday, January 15th. Finally, Credit Suisse Group set a €82.00 ($95.35) price target on Gerresheimer and gave the stock a buy rating in a research report on Tuesday, February 5th. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and four have given a buy rating to the company. The company presently has an average rating of Hold and an average target price of €68.77 ($79.97).

Gerresheimer stock opened at €58.00 ($67.44) on Monday. Gerresheimer has a 12-month low of €59.97 ($69.73) and a 12-month high of €78.25 ($90.99).

Gerresheimer Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Featured Story: Understanding Specialty Certificates of Deposit

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.